Navigation Links
Purple tomatoes: The richness of antioxidants against tumors
Date:10/26/2008

Researchers from the John Innes Centre in Norwich, Great Britain, in collaboration with other European centres participating to the FLORA project, have obtained genetically modified tomatoes rich in anthocyanins, a category of antioxidants belonging to the class of flavonoids. These tomatoes, added to the diet of cancer-prone mice, showed a significant protective effect by extending the mice lifespan. The research has been published in the 26 October issue of Nature Biotechnology.

It is a remarkable step ahead in the study on antioxidants, particularly flavonoids, widely considered as a useful tool for preventing a large number of diseases, from cardiovascular disease to certain types of can-cer. The diet followed by the majority of people living in the Western world does not appear to be suffi-cient to guarantee an adequate intake of these substances, present in many fruits and vegetables such as berries. That is why the FLORA project aims at understanding their mechanisms trying to find new ways to increase their consumption.

Researchers from the John Innes Centre, coordinated by Cathie Martin, tried to step on it by putting on the lab bench a naturally anthocyanins-free product as tomato and engineering it to enhance its flavonoid content. In this way researchers have obtained an ideal model to study the effect of anthocyanins.

In order to obtain fruit particularly rich in anthocyanins, that has conferred a peculiar purple colour to the tomatoes, the British team has used two genes from the snapdragon flower: Delila and Rosea1. "Our insti-tute has a long standing interest in this plant that we use as a model to study flower development- says lead author Eugenio Butelli- The two genes we have isolated are responsible for flower pigmentation and, when introduced in other plants, turned out to be the perfect combination to produce anthocyanins, the same phytochemical found in blueberries. At a closer chemical analysis it
'/>"/>

Contact: Americo Bonanni
bonanni@filemazio.net
39-347-930-5981
Catholic University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Fried purple tomatoes
2. Purple extremist thrives under inhospitable conditions
3. Research shows Brazilian acai berry antioxidants absorbed by human body
4. Antioxidants could provide all-purpose radiation protection
5. Clemson chemists discover new way antioxidants fight debilitating diseases
6. Research identifies type of vaccine that holds promise in protecting against TB
7. Wielding microbe against microbe, beetle defends its food source
8. Vitiligo skin disorder could yield clues in fight against melanoma
9. Friendly bacteria protect against type 1 diabetes, Yale researchers find
10. Bats pick up rustling sounds against highway background noise
11. Vaccine against HER2-positive breast cancer offers complete protection in lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2015)... DUBLIN , Mar. 19, 2015 Research and Markets ... the "Iris Biometrics - Global Strategic Business Report" ... worldwide markets for Iris Biometrics in US$ Thousands. The report ... , Japan , Europe ... East , and Latin America . ...
(Date:3/17/2015)... 2015 Emotient, the leader in facial ... general availability of Emotient Analytics , the ... of facial expressions. The system analyzes videos of ... and services. It delivers audience response metrics - ... as derived from facial evidence of emotional states. ...
(Date:3/12/2015)... , March 12, 2015 The mascots of ... Children,s Hospital, part of Wake Forest Baptist Medical Center. ... for the 2015 ACC Men,s Basketball Tournament. Young patients ... them and getting their autographs. Brenner Children,s ... It is the only children,s hospital in northwest ...
Breaking Biology News(10 mins):Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... than 400 million years, the horseshoe crab is now ... destruction. However, climatic changes may,also play a role. Researchers ... crab populations are to natural climate change in a ... . The horseshoe crab is often regarded as ...
... release is available in German . , Tobias Brgmann ... I used a so-called "channelrhodopsin" for their experiments, which is a ... as an ion channel in the cell membrane. When stimulated with ... cell. This causes a change in the cell membrane,s pressure, which ...
... the poles almost everywhere in the world, except along ... snails Steffen Kiel and Sven Nielsen at the Christian-Albrechts-Universitt ... originated at the end of the last ice age, ... a mosaic landscape of countless islands, bays and fiords ...
Cached Biology News:Climate change affects horseshoe crab numbers 2Bonn researchers use light to make the heart stumble 2Disappearing glaciers enhanced biodiversity 2
(Date:3/30/2015)... March 30, 2015  Naldemedine, an investigational peripherally ... Shionogi & Co., Ltd., met its primary and ... I) for the treatment of opioid-induced constipation (OIC) ... opioid therapy. Study results showed that naldemedine (0.2 ... the frequency of spontaneous bowel movement (SBM) compared ...
(Date:3/29/2015)... 2015 Caris Life Sciences® today ... showing the presence of PD-1 and PD-L1 ... Using Caris Molecular Intelligence®, the company,s panomic ... of programmed cell death protein-1 (PD-1) in ... its ligand (PD-L1) expression was variable across ...
(Date:3/27/2015)... -- Neogen Corporation (NASDAQ: NEOG ) announced today that ... in accordance with Securities and Exchange Commission rule 10b5-1. ... Corporation, is a minority owner of this entity that ... Herbert does not have control of this entity, but ... for a portion of the shares owned by that ...
(Date:3/27/2015)... 27, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , today ... ended December 31, 2014.  The Company ... per share, for the three months ended December 31, ...
Breaking Biology Technology:Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4Neogen CEO adopts 10b5-1 Trading Plan 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6
... that the economy is not,only heading towards a recession ... mood during January. However, biotech held steady,with the Burrill ... which posted a January loss of 9.9%, and the ... to ride out extremely volatile capital,markets with less damage ...
... BODY WORLDS 2:,The Original Exhibition of Real Human ... Saturday, February 2nd. The acclaimed exhibition,includes the East ... special feature on,the brain., BODY WORLDS presents ... and unhealthy organs, body section and slices, all,preserved ...
... Pollard Brings the Highest Level of Clinical Immunology ... 1 Genetic,Immunity(R), a US/Hungarian clinical-stage biopharmaceutical company,focused ... platform technology, announced that it has appointed,Richard B. ... Pollard has been a leader in HIV/AIDS research ...
Cached Biology Technology:January Market Jitters Fails to Derail Biotech 2January Market Jitters Fails to Derail Biotech 3January Market Jitters Fails to Derail Biotech 4Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2 2Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 2Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 3
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets USA ...
... 2 Detection System combines the indirect ... principle and Signets unique formulation of ... and reliablility. Signet reagents will achieve ... and automated protocols. ,Signets USA Detection ...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets ...
Each bottle contains: Bromophenol Blue 0.25% w/v , Xylene Cyanol FF 0.25%, Glycerol solution 30% w/v...
Biology Products: